PLoS ONE
Home Characteristics of adolescents aged 15-19 years living with vertically and horizontally acquired HIV in Nampula, Mozambique
Characteristics of adolescents aged 15-19 years living with vertically and horizontally acquired HIV in Nampula, Mozambique
Characteristics of adolescents aged 15-19 years living with vertically and horizontally acquired HIV in Nampula, Mozambique

Competing Interests: The authors have declared that no competing interests exist.

Article Type: Research Article Article History
Abstract

Background

Adolescents living with HIV (ALHIV) 15–19 years of age are a growing proportion of all people living with HIV globally and the population includes adolescents with vertically acquired HIV (AVH) and behaviorally acquired HIV (ABH).

Methods

We conducted a survey to measure sociodemographic characteristics, educational status, health history, and antiretroviral therapy (ART) adherence among a convenience sample of ALHIV at three government health facilities in 2019 in Nampula, Mozambique. ALHIV 15–19 years on ART, including females attending antenatal care, were eligible. Routine HIV care data were extracted from medical charts. Classification of ALHIV by mode of transmission was based on medical charts and survey data. ALHIV who initiated ART <15 years or reported no sex were considered AVH; all others ABH. Frequencies were compared by sex, and within sex, by mode of transmission (AVH vs. ABH) using Chi-square, Fishers exact tests and Wilcoxon rank-sum tests.

Results

Among 208 ALHIV, 143 (69%) were female and median age was 18 years [interquartile range (IQR) 16–19]. Just over half of ALHIV (53%) were in or had completed secondary or higher levels of education; the most common reason for not being in school reported by 36% of females was pregnancy or having a child. Of all ALHIV, 122 (59%) had VL data, 62% of whom were <1000 copies/mL. Almost half (46%) of ALHIV reported missing ARVs ≥ 1 day in the past month (62% of males vs. 39% of females; p = 0.003). Just over half (58%) of ALHIV in relationships had disclosed their HIV status: 13% of males vs. 69% of females (p<0.001). Among sexually active males, 61% reported using a condom at last sex compared to 26% of females (p<0.001). Among female ALHIV, 50 (35%) were AVH and 93 (65%) were ABH, 67% of whom were not in school compared to 16% of ABH, (p<0.001).

Discussion

Data from our study underscore the high level of deprivation among ALHIV enrolled in HIV care in Mozambique, as well as important disparities by sex and mode of transmission. These data can inform the development of effective interventions for this complex and important population.

Teasdale,Brittain,Zerbe,Mellins,Falcao,Couto,Pimentel De Gusmao,Vitale,Kapogiannis,Simione,Myer,Mantell,Desmond,Abrams,and Marotta: Characteristics of adolescents aged 15-19 years living with vertically and horizontally acquired HIV in Nampula, Mozambique

Introduction

Adolescents living with HIV (ALHIV), ages 15–19 years, are a growing proportion of all people living with HIV globally and the vast majority (88%), approximately 1.5 million, live in sub-Saharan Africa (SSA) [1,2]. Compared to adults and children, ALHIV have worse outcomes across the HIV care continuum, with lower testing, antiretroviral therapy (ART) coverage, and viral suppression rates [36]. Data from the Population-based HIV Incidence Assessments (PHIA) conducted in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe found that only 56% (95% CI 50–62) of ALHIV 15–19 years were aware of their HIV-positive status; among ALHIV with known status, 50% (95% CI 44–56) were on ART and only 35% (95% CI 30–41%) on ART had a suppressed HIV viral load (VL<50 copies/mL) [7]. As a result of the low coverage and uptake of services, HIV is the leading cause of death for adolescents 10–19 years of age in SSA [1]. Mozambique is one of the ten countries with the highest burden of adolescent HIV globally, with approximately 140,000 ALHIV and 7% HIV prevalence among females 15–19 years of age, yet there have been few studies describing the characteristics of this population [8,9].

The ALHIV population is comprised of adolescents with vertically acquired HIV-transmission (AVH) and behaviorally acquired HIV (ABH) [1,8,10]. While the population of AVH has increased as a result of efforts over recent decades to improve pediatric diagnosis and expand access to ART leading to better survival among children living with HIV [11,12], the increasing population of ABH is driven by alarmingly high HIV infection rates among young women 15–24 years of age [13]. In SSA, adolescent and young women are up to six times more likely to acquire HIV compared to males the same age and they account for one of every five new HIV infections despite representing only 10% of the population [10,14].

Adolescence is a critical period of physical, emotional, and social development, characterized by heightened vulnerability and challenges which may impact adherence to HIV care and ART [15]. Mode of transmission may impact how adolescents navigate their HIV status and care. For many AVH, adolescence is when they learn their HIV status [16] which occurs in the context of emerging independence, including responsibility for their own care and disclosing their HIV status to peers and sexual partners [1719]. In addition, AVH may need more complex clinical care as a result of late ART initiation as well as long-term use [20,21]. They may also experience medication fatigue and other adherence challenges which have been observed among adolescents with other chronic diseases [2224]. ABH may face different barriers to achieving optimal treatment outcomes. As noted, ABH in SSA are predominantly young women who are more likely to experience gender-based violence and gender inequality [10]. In addition, many female ABH are identified as a result of pregnancies [25,26] which entail new responsibilities that can make engagement in care and adherence to ART more difficult [27,28].

Understanding and characterizing the ALHIV population in SSA with consideration of sex and mode of transmission may aid in the development and implementation of more effective models of HIV care and targeted interventions to improve outcomes; however, few studies of ALHIV from SSA have disaggregated results in this way [2931]. We report data from a survey of ALHIV 15–19 years of age enrolled in HIV care in Nampula, Mozambique, in order to provide a more robust picture of the demographic, biomedical, psychosocial and behavioral characteristics of this key population based on sex and likely mode of transmission.

Methods

The survey data reported in this analysis were collected during the first phase of the CombinADO study (UG3HD096926) which will test a multicomponent intervention to improve HIV care and treatment outcomes for ALHIV in Mozambique [32].

Participants and procedures

The study was conducted at three government health facilities from June through December 2019 in the city of Nampula in northern Mozambique. All ALHIV 15–19 years of age who were enrolled in HIV care at the health facilities, including females attending antenatal care, were considered eligible to participate. Study staff reviewed facility reports to estimate the number of eligible participants; facility nurses provided information to ALHIV at routine care visits and referred them to study staff for more information and potential enrollment. Informed consent was obtained from ALHIV who were aged 18–19 years or emancipated, while assent was obtained from ALHIV aged 15–17 years with consent from their adult caregivers. Participants were given transportation reimbursement equivalent to $5 USD following survey completion. Study staff administered the surveys in Portuguese via electronic tablets to ALHIV in private spaces in health facilities.

Measures

The quantitative survey was guided by Bronfenbrenner’s social-ecological model (SEM) addressing individual-level characteristics and health behaviors, interpersonal factors as well as higher level structural and contextual risk factors that may influence retention in care, ART adherence, and HIV viral suppression (S1 Fig) [33]. Individual-level factors measured in the survey included demographic characteristics of the adolescent, their caregivers and households, educational and employment status, as well as medical history, substance use, health beliefs and knowledge, ART adherence, and readiness for independent health care. The interpersonal domain covered relationship/marital status, sexual behavior, HIV disclosure, community engagement and pregnancy. Data collected on the institutional/health system characteristics are not reported in this analysis.

The survey included validated scales that were adapted for adolescents and translated into Portuguese and back-translated into English using recommended procedures [34]. Self-reported adherence was assessed using a tool developed by Wilson and colleagues which has been validated in the United States and South Africa [35]. The tool measures adherence reported over the past 30 days with three questions on: number of days with a missed ART dose, frequency with which respondents took ART the way they were supposed to and rating of how good a job they did taking their medications the way they were supposed to, the latter two items rated on a 5-point Likert scale). Self-reported adherence over the past 30 days was calculated for each participant by re-coding and weighting each item and then calculating the score ranging from 0–100% [35,36]. We also measured knowledge about HIV using ‘true’/’false’/‘don’t know’ responses to statements about HIV transmission, viral load measurements and ART adherence using questions adapted from previous HIV surveys [2,37]. For the analysis, we dichotomized responses into incorrect/‘don’t know’ and correct for each question. To measure stigma and self-perceived stigmatization, we adapted the Social Impact Scale which measures responses across four dimensions of internalized and externalized stigma: social rejection, financial insecurity, internalized shame, and social isolation [38]. Participants were asked to indicate their agreement with statements about how they have been treated and how they feel about their HIV-positive status (for the presentation of results, we combined ‘strongly agree’ with ‘agree’ and ‘strongly disagree’ with ‘disagree’). As this study was conducted with adolescents who are less likely than adults to have disclosed their HIV-positive status to others [39,40] and thus may not have experienced stigma due to non-disclosure, an additional response option indicating non-disclosure (yes/no) was added to each item on the scale to help us differentiate lack of stigma experiences due to lack of disclosure from lack of stigma experiences. The London Measure of Unplanned Pregnancy (LMUP), which has been validated in sub-Saharan Africa, was used to collect information from women who were currently pregnant [41]. Mode of transmission was not collected directly from ALHIV in this study and is not recorded routinely in medical charts; thus, we estimated mode of transmission based on available information. ALHIV were considered AVH if they initiated ART before the age of 15 years (based on self-report or medical chart), or if they reported never having vaginal intercourse; all other ALHIV were considered ABH (S2 Fig).

Study staff administered the surveys in Portuguese via electronic tablets to ALHIV in private spaces in health facilities. Routine data on participant HIV care and treatment history were extracted from medical charts, including HIV diagnosis and ART initiation dates, ART regimens and viral load (VL) measures. The protocol was approved by the Columbia University Irving Medical Center (CUIMC) Institutional Review Board (IRB) and the Comité Nactional de Bioética para Saúde of the Ministry of Health in Mozambique.

Data analysis

We present descriptive data on the characteristics of ALHIV 15–19 years of age. We also examined characteristics according to sex and estimated mode of transmission (vertical vs. behavioral). Frequencies were compared by sex groups (all males compared to all females) and, among male and females separately, by mode of transmission (AVH vs. ABH) using Chi-square and Fishers exact tests for categorical and Wilcoxon rank-sum tests for continuous variables; p-values are presented for the comparison across all levels of multi-level categorical variables (for questions with multiple response options, binary variables were created for each option).

Results

An estimated 310 ALHIV 15–19 years of age and active on ART were registered at the two facilities where the study was initially implemented. A total of 296 ALHIV (81 male, 215 female) were referred by site nurses for screening. Of these, 233 (60 male, 173 female) were eligible and 195 enrolled, including 49 males (82%) and 146 females (84%). Due to the low number of males enrolled, a third health facility was added that had 31 male ALHIV on ART, 18 of whom were referred for screening and all 18 were eligible and enrolled for a total of 213 participants. Data from 5/213 participants were excluded from this analysis because the participants were not aware of their HIV-positive status.

Individual-level characteristics (Tables 1 & 2, Fig 1)

Proportion of ALHIV 15–19 years answering HIV knowledge questions correctly by sex and mode of transmission (vertically vs. behaviorally acquired HIV), Nampula, Mozambique, 2019 (N = 208).
Fig 1

Proportion of ALHIV 15–19 years answering HIV knowledge questions correctly by sex and mode of transmission (vertically vs. behaviorally acquired HIV), Nampula, Mozambique, 2019 (N = 208).

Table 1
Demographic characteristics of adolescents living with HIV 15–19 years of age enrolled in care at three health facilities in Nampula, Mozambique, 2019 (N = 208).
TotalMalesFemales
N%N%N%p-value
208100653114369
Age, median (IQR)18 (16–19)17 (15–18)18 (17–19)<0.001
Age at ART initiation, median (IQR)16 (12–18)13 (9–16)17 (15–18)<0.001
Don’t know23115.0818130.35
Household characteristics & resources
Muslim7737284349340.50
Catholic713420315136
Protestant/Evangelic522516253625
Other/no religion841275
Primary caregiver
Mother673228433927<0.001
Father261310151611
Sister/brother199914107
Aunt/uncle199812118
Grandmother/grandfather13671164
Partner (husband, boyfriend)3115003122
Self3014122920
Other312311
Primary provider of financial support
Mother462214223222<0.001
Father462221322518
Other family432124371913
Partner5928005941
Self521243
Other945843
Household facilities
Inside toilet693345702417<0.001
Running water482330471814<0.001
Electricity158765586103720.03
Adolescent or caregiver can afford
Visit to the doctor when you are ill201976195140980.38
Three meals a day164794773117820.17
School fees (n = 128)12396549869950.39
All of the medicines needed191925688135940.09
Not enough food ≥1 day past week492431481813<0.001
Cell phone ownership
Has own cell phone9546304665460.86
Shares a cell phone562716254028
No cell phone572719293827
Has accessed the internet773735544229<0.01
Frequency of internet
Daily3242164616380.65
Weekly334315431843
Monthly or more1216411819
Substance use (ever)
Tobacco525800<0.01
Alcohol261314221280.01
Marijuana3135000.03
Education & employment
Current school enrollment
Primary (first and second)199111786<0.001
Secondary (first and second)1065143666344
Technical or vocational school211211
University, college or other tertiary211211
Not in school79389147049
Highest grade completed (n = 79)
None4500460.91
Incomplete primary35445563043
Primary education7900710
Incomplete secondary27343332434
Secondary education6811157
Reasons for not attending school
Finished34111230.31
Couldn’t pay school fee/uniforms202555615210.04
Stopped to help at home/get job911009130.59
Too unwell68111570.53
Parent/guardian died23111110.22
Got married17220017240.19
Pregnancy/had child25320025360.05
Moved810222690.23
Other141811113191.00
Employment status
Currently employed7312640.66
Previously employed16846128
Never employed18589609212587
Self-reported health status
Current health status
Excellent/very good4723142233230.01
Good1065127427955
Fair351720311511
Poor2010461611
Past year
Too sick to attend work/school ≥1 day753635544028<0.001
≥1 night in hospital21108121390.48
TB diagnosis147711750.12
Ever diagnosed or treated for STI3316353021<0.01
Past 6 months symptoms reported sometimes or often
Asthma, lung problems and trouble breathing for > 2 days4421152329200.65
Bad cough10852365572500.50
Night sweats7235192953370.26
Ulcers in mouth or problems swallowing food4723132034240.55
Diarrhea >2 days in a row9445324962430.43
Weight loss/inability to put on weight9346253968490.16
Smelly vaginal or penile discharge4220583726<0.01
Medical chart data
CD4 cell count measure past year2713111716110.25
Median CD4 cell count (IQR)644 (508, 803)579 (363, 694)734 (567, 841)0.14
Viral load measure past year12259416381570.38
Median log10 viral load (IQR)1.7 (1.7, 4.1)2.9 (1.7, 4.3)1.7 (1.7, 3.6)0.21
<50 copies/mL6150174244540.18
<1000 copies/mL7562225453650.21
Regimen (11 missing regimen data)
TDF+3TC+EFV14272243911887<0.001
TDF+3TC+DTG30152032107
2 NRTI+PI (ATZ/r, LPV/r)147111832
AZT+3TC+NVP845832
Other322311

*TDF: Tenofovir, 3TC: Lamivudine, EFV: Efavirenz, DTG: Dolutegravir, NRT: Non-nucleoside reverse transcriptase inhibitors including AZT: Zidovudine or ABC: Abacavir, ATZ/r: Atazanavir/ritonavir, LPV/r: Lopinavir/ritonavir, NVP: Nevirapine.

Table 2
Self-reported health status, adherence and health autonomy among adolescents living with HIV 15–19 years of age care at three health facilities in Nampula, Mozambique, 2019 (N = 208).
TotalMalesFemales
N%N%N%p-value
208100653114369
ART responsibility
Frequency of ART pick-up
Monthly161774265119830.01
Every 3 months452222342316
Other211211
Takes one ARV pill per day15575385911782<0.001
Knows prescribed ARV names8469210.01
Person responsible for administering ART1.00
Self19192609213192
Caregiver1053575
Both self and caregiver732354
Self-reported ART adherence
Missed ARVs ≥ 1 day in past 30 days964640625639<0.01
Took ART as instructed past 30 days
Always1135446716747<0.01
Almost always693311175841
Sometimes/usually199812118
Never/rarely730075
Did a good job taking ART as instructed past 30 days
Very poor/poor6312540.13
Fair291413201611
Good763727424934
Very good/excellent974724377351
Difficulty taking ARVs as instructed
Not hard/not very hard184896295122850.10
Somewhat hard189231611
Extremely hard/very hard631254
3-item adherence score, median (IQR)89 (81–94)87 (81, 93)89 (81, 94)0.48
Reported reasons for any missed ART doses past 30 days
None missed1115325398660<0.01
Forgot6330253938270.08
Different routine211011171070.03
No food to take with ARVs15769960.45
Ran out8458320.11
Unwell or vomiting6346210.08
Didn’t like taste5223320.65
Fed up or tired or taking ARVs4223210.59
Did not want others to see ARVs3112211.00
Readiness for independent care
Keeps track of clinic appointments
Always on own154745077104730.55
With help from caregiver34168122618
Caregiver always does2010711139
Always attends clinic on own180875585125870.58
Explain health issues to provider
Always on own173834975124870.07
With help from caregiver271313201410
Caregiver always does732354
N/A (doesn’t do)111200
Tracks stock of own medications
Always on own1115325398660<0.001
With help from caregiver341614222014
Caregiver always does27131726107
N/A (doesn’t do)36179142719
Know when to take medication
Always on own199966194138970.16
With help from caregiver732354
Caregiver always does212300

Individual and household characteristics

Among 208 ALHIV who were included in the analysis, 65 (31%) were males and 143 (69%) were female (Table 1). Median age of participants was 18 years [interquartile range (IQR) 16–19] and median age at ART initiation was 16 years [IQR 12–18]. Males were younger at ART initiation (13 years, IQR 9–16) compared to females (17 years, IQR 15–18) (p<0.001). A third of all ALHIV (32%) reported mothers as primary caregiver. Females were more likely to report partners (22%) or themselves (20%) as their primary caregivers whereas no males reported partners and 1 (2%) reported himself (p<0.001). While most ALHIV (76%) had electricity in the home, only 33% had inside toilets and 23% had running water. Significantly higher proportions of males had access to household facilities (Table 1). While almost all ALHIV reported having enough money to seek medical care (97%) and pay for medications (92%), 24% reported not having enough food in the home in the past week, with males more likely to report this than females (48% vs. 13%; p<0.001). Less than half (46%) of ALHIV had their own cell phone and only 37% had ever accessed the internet (54% of males vs. 29% of females, p = 0.001). Very few ALHIV reported ever using tobacco (2%), alcohol (13%) or marijuana (1%) (no females reported tobacco or marijuana use).

Education & employment

Just over half of ALHIV (53%) were in or had completed secondary or higher levels of education; 9% were in primary school and 38% were not in school (Table 1). For males, the primary reason for not completing school was not being able to pay fees (56%), while the most common reason reported by females was a pregnancy or having a child (36%). Only 3% of all ALHIV reported being currently employed; most (89%) reported never having been employed.

Self-reported health status

Most ALHIV reported excellent (23%) or good (51%) health status’ however, more males reported current health status as fair or poor compared to females (37% vs. 22%; p = 0.005) (Table 1). Sixteen percent of ALHIV reported ever having been diagnosed with a sexually transmitted infection (STI), 5% of males compared to 12% of females (p<0.001). Many ALHIV reported ailments in the past six months, including a bad cough (52%), weight loss (46%) or night sweats (45%).

Medical chart data

Only 122 (59%) ALHIV had VL data in medical charts (Table 1). Median log10 VL was 1.7 copies/mm3 (IQR 1.7–4.1) and 62% of ALHIV with a VL measure had <1000 copies/mL. Most ALHIV (72%) were on an ART regimen containing tenofovir (TDF), lamivudine (3TC), and efavirenz (EFV) and 15% received TDF+3TC+dolutegravir (DTG).

Health knowledge and beliefs

Responses to questions measuring knowledge about HIV transmission and treatment are shown in Fig 1. Most ALHIV understood how ARVs work (82%) and that they can prevent vertical transmission (83%); however, few provided correct responses to questions about viral load. More males than females knew what VL measures (66% males vs. 50% females; p = 0.03); that when VL is undetectable, transmission is less likely (55% males vs. 35% females; p = 0.006); and that they need to take ARVs every day (86% males vs. 73% females; p = 0.04).

Responsibility for ART administration

Most ALHIV (77%) picked up medication monthly rather than quarterly (Table 2). Almost all ALHIV (92%) reported being responsible for administering their own ART. However, only 8 ALHIV (4%) knew the names of the ARVs they were prescribed.

Self-reported ART adherence

Almost half (46%) of ALHIV reported missing ARVs at least one day in the past month with males more likely than females to report missed ARV doses (62% vs. 39%; p = 0.003) (Table 2). Overall, 47% of ALHIV reported ‘very good’ or ‘excellent’ taking of medication and 89% said it was ‘not hard’ or ‘not very hard’. The median 3-item adherence score for the past 30 days was 89% (IQR 81–94), with no difference by sex. The most commonly reported reasons for missing ARV doses in the past month was forgetting (30%), changes in routine (10%) and no food to take with medication (7%). A higher proportion of males reported adherence challenges resulting from ‘changes to routine’ compared to females (17% vs. 7%; p = 0.028).

Interpersonal-level characteristics (Tables 35)

Table 3
Relationship status, HIV stigma/disclosure and community engagement among ALHIV 15–19 years of age enrolled in HIV care in Nampula, Mozambique, 2019 (N = 208).
TotalMalesFemales
N%N%N%p-value
208100653114369
Current relationship
Currently in a relationship1205823359768<0.001
Current relationship status<0.001
Married and living together4235004243
Married but not living together1513001516
Not married but living together760077
Not married and not living together5344231003031
Other330033
Current relationship length, median (IQR) months12 (6,24)5 (2,12)12 (7,24)0.01
Age of partner, median (IQR) age22 (19,25)16 (15,18)23 (21,26)<0.001
Age at marriage (n = 57), median (IQR)17 (16,18)-17 (16,18)-
Partner is parent of a participant’s child (n = 58)4883004883-
Other sexual partners in last year (n = 111)17156431111<0.01
HIV status disclosure
Remembers age when first learned HIV status197956397134940.51
Age learned HIV status, median (IQR)16 (14, 18)14 (13, 15)17 (15, 18)<0.001
How learned HIV status<0.01
On own (no one told)521243
Told by doctor/nurse864118286848
Told by family at home2311142296
Told by family at clinic924431486143
Don’t remember/other211211
Other household members with HIV
Mother5024132037260.36
Father20104616110.32
Brother/sister341671127190.14
Aunt/uncle20101117960.02
Grandmother/grandfather6369000.00
Partner (wife/husband, boyfriend/girlfriend)1571214100.04
Other4120223419130.00
Don’t know7235182854380.16
Primary caregiver knows adolescent’s HIV status<0.001
Yes1406762957855
No4522124431
Don’t know2311232115
Household members know adolescent’s HIV status0.02
None2110122014
Few1215840628157
Most all612922343927
Don’t know522332
Family outside household know adolescent’s HIV status0.87
None854125396042
Few934529456445
Most all2010711139
Don’t know1054664
Disclosed HIV status to current partner among those with partners (n = 120)70583136769<0.001
Knows current partner’s HIV status (n = 120)56473135355<0.001
Current partner’s HIV status (n = 56)0.56
HIV-positive22392672038
HIV-negative34611333362
Friends know adolescent’s HIV status0.35
None18489558512990
Few16881286
Most all210021
Don’t know632343
Teachers know adolescent’s HIV status among those in school (n = 127)0.40
None1219552936997
Some654723
Community engagement
Member of a youth organization(s)
Gospel choir/church group37186931220.03
Activist organization/youth association189142243<0.001
Sports team115914210.00
Music/singing/arts performance group8423641.00
Any above6532264139280.08
Past year involved/participated in following:
Cultural or religious organization7135243847340.61
Sports or Recreation44223352118<0.001
Performing Arts (theater, music, etc.)4020142226190.60
Academic or Pre-Professional Society9435641.00
Government or Political Organization4200430.31
Community Based Organization5323320.65
Media (newspaper, radio, TV, etc.)8458320.11
Other1100111.00
Table 4
Sexual behaviors and condom use among ALHIV 15–19 years of age who have had vaginal intercourse in Nampula, Mozambique, 2019 (N = 140).
TotalMalesFemales
N%N%N%p-value
140100332410776
Portion of all ALHIV in survey who had sex14067335110775<0.01
Sexual behavior history
Age at first sex, median (IQR) age1615, 171514, 161615, 170.01
Age of first sexual partner, median (IQR)1815, 201514, 161918, 21<0.001
Forced first sex (all)302282422210.69
Forced first sex0.68
Physically forced1033225836
Pressured20676751464
Reason for first sex
Wanted to try it7554185557530.01
Partner wanted to have sex23168241514
To show love/to feel loved2316262120
Pressure from friends643933
For money or gifts212600
Wanted to have a baby210022
Other/don’t know960098
Total number of sex partners, median (IQR)21, 321, 421, 30.34
Number sex partners last 12 months, median (IQR)1 (1,1)1 (0, 2)1 (1,1)0.16
Sex in exchange for money or gifts201441216150.78
Sources of information about sex and reproductive health
Friends6748195848450.20
Someone at the clinic6748144253500.48
School3726154622210.01
Internet24171442109<0.001
Caregiver12939981.00
The media11826981.00
Older siblings11882433<0.001
Other9613880.69
Condom use
Condom used last sex473420612726<0.001
Reasons for not using condom last sex act (n = 93)
Partner refused6065185974<0.001
Did not have a condom20227541316<0.01
Felt safe without a condom7800790.59
Wanted to become pregnant or get my partner pregnant6700680.59
Other1112539680.01
Condom use
Always261915461110<0.001
Sometimes47348243937
Never64469275551
Don’t remember321322
Reasons for condom use over past year (n = 140)
Prevent pregnancy3525113324220.21
Prevent HIV transmission2921103019180.12
Prevent getting infected with STIs201482412110.06
Prevent reinfection with HIV139412980.51
Other/don’t know332441229270.10
No condom use last year5237113341380.60
Table 5
Pregnancy status and history among female ALHIV 15–19 years of age in Mozambique who had ever been pregnant (N = 84).
AllAVHABHp-value
N%N%N%
84100787792
Proportion of all females with history of pregnancy591454
Total number of pregnancies (including current)1.00
161735715673
220242291823
3340034
Number of children given birth to who are living (n = 58)1.00
061012559
145782504380
2712125611
Number of biological children living with adolescent (n = 58)0.21
0712125611
145782504380
261012559
Number biological children tested HIV-positive (n = 58)1.00
0467941004278
171200713
2120012
Unknown470047
Age at most recent pregnancy, median (IQR)17 (16,18)17 (15,17)17 (16,18)0.05
Adolescent trying to get pregnant at time of last pregnancy587045754710.53
Currently breastfeeding374411436470.13
Currently pregnant232722921271.00
In the month that became pregnant….0.17
Self/partner not using contraception21911502095
Self/partner using contraception sometimes1415000
Self/partner used but knew method had failed at least once140015
Self/partner always used contraception000000
Timing of pregnancy0.68
Right time1044150943
Ok, but not quite right time83500838
Wrong time522150419
Pregnancy intentions at time of pregnancy1.00
Intended to get pregnant11481501048
Changing intentions31300314
Did not intend to get pregnant939150838
Intentions to have baby at time of pregnancy0.46
Wanted to have a baby12521501152
Mixed feelings about having a baby62600629
Did not want to have a baby522150419
Currently receiving antenatal care2296150211000.09
Health facility—pre-natal clinic83611007330.36
Health facility—Adolescent services (SAAJ*)1464001467
Plans to delivery baby in1.00
Health facility/hospital229621002095
I don’t know140015
Plans to continue taking ART after delivery23100210021100-
Plans to continue taking ART after stops breastfeeding2296210020951.00

*SAAJ Servicios Amigos dos Adolescentes.

Current relationship

Among 208 ALHIV, 121 (58%) reported a current relationship (35% of males and 69% of females; p<0.001) (Table 3). No males in relationships were married or cohabitating whereas more than half of females in relationships were married (59%) (p<0.001). Most males reported current relationships with other adolescents (median partner age: 16 years, IQR 15–18), whereas females were more likely to have adult partners (median partner age: 23 years, IQR 21–26) (p<0.001).

HIV status disclosure

Among all ALHIV, median age when they learned their HIV status was 16 years [IQR 14–18]; males were younger at HIV disclosure (14 years, IQR 13–15) compared to females (17 years, IQR 15–18) (p<0.001) (Table 2). Two-thirds (67%) of ALHIV reported that their primary caregiver knew the adolescent’s status (95% of males vs. 55% of females, p<0.000). Just over half of the 121 ALHIV (58%) with partners had disclosed to their partner; 13% of males vs. 69% of females (p<0.001). Less than half (47%) of ALHIV in relationships reported knowing their partner’s HIV status (13% of males and 55% of females, p<0.001). Most ALHIV (89%) reported that none of their friends knew they were living with HIV.

Community engagement

A third (32%) of all ALHIV reported involvement in youth organizations, including choirs or church groups, activist or youth associations, sports teams, or other arts groups (Table 3). Thirty-five percent reported cultural or religious organization participation and 22% reported participation in sports.

Social impact

On 8 out of the 15 Social Impact Scale items, more than 50% of females reported that they had not disclosed their HIV-positive status (S4 Table). Fig 2a–2d show responses to the items where the highest proportion of participants had disclosed. Among all ALHIV, 76% reported that they needed to keep their HIV a secret (86% of males and 71% of females, p<0.001) and 52% feared someone telling others about their HIV status (42% of males and 57% of females, p<0.0001) (Fig 2). A higher proportion of males (68%) than females (16%) agreed with the statement that they were partially to blame for their HIV (p<0.0001).

a-d. Responses to items on the Social Impact Scale from Mozambican ALHIV 15–19 years by sex and mode of HIV infection (N = 208).
Fig 2

a-d. Responses to items on the Social Impact Scale from Mozambican ALHIV 15–19 years by sex and mode of HIV infection (N = 208).

Sexual behavior

Among the 140 (66%) ALHIV who reported having had sexual intercourse, age at first sex was 16 years [IQR 15–17]; 15 years [IQR 14–16] for males and 16 years [IQR 15–17] for females (p = 0.006) (Table 4). Whereas males reported first sex with partners of the same age (median 15 years, IQR 14–16), first partners for females were older (19 years, IQR 18–21) (p<0.001). Overall, 22% of ALHIV reported their first sexual experience was forced, and among those, 33% said it was physically forced. Among all ALHIV, 14% reported ever having sex in exchange for money or gifts. More than half of sexually active males (61%) reported using a condom at their last sexual encounter, whereas only 26% of females reported condom at last sex (p<0.001) (Table 4).

Pregnancies and children

Among 143 female ALHIV, 84 (59%) had ever been pregnant (Table 5). Of 58 who had given birth to a child that was living, eight children (14%) were reported to have tested HIV-positive. The median age at the most recent pregnancy was 17 years (IQR 16–18) overall. At the time of the survey, 23 (27%) females were currently pregnant and 37 (44%) were breastfeeding. Among those who were pregnant, 91% said that in the month she became pregnant neither she nor her partner were using contraception. When asked about intentions at the time of the pregnancy, 39% said it was unintended.

Analysis by estimated mode of transmission

We also examined characteristics according to estimated mode of transmission within sex. Among female ALHIV, 50 (35%) were AVH and 93 (65%) were ABH (S1 Table). Female ABH were older at treatment initiation, 18 years (IQR: 17–19) and at study, also 18 years (IQR: 18–19) compared to AVH who were 12 years (IQR: 9–16) at ART initiation and 16 years (IQR: 15–18) at study (p<0.001; p<0.001). A higher proportion of female ABH reported partners (30%) or themselves (20%) to be primary caregivers compared to female AVH (6% and 2%, respectively) (p<0.001). Significantly lower proportions of female ABH compared to AVH had an inside toilet (11% vs. 28%, p = 0.008) or running water (5% vs. 26%, p = 0.001). Only 19% of female ABH had ever accessed the internet (compared to 48% of AVH; p<0.001) and 67% were not in school (compared to 16% of AVH, p<0.001). Among female ABH not in school, 7% reported no schooling and 42% reported incomplete primary school (S1 Table). Female ABH also had less knowledge about HIV, particularly with regard to VL, and only 61% of ABH knew that they should not miss any doses of ARVs (compared to 78% of AVH, p = 0.04) (Fig 1). Based on self-reported adherence, a higher proportion of female ABH (19%) compared to AVH (2%) reported sometimes or never/rarely taking their ARVs over the past month (p = 0.04) (S2 Table). AVH females were more likely than ABH to have had a VL measurement, but rates of suppression were similarly low in both groups (51% vs. 57%, < 50 copies/mL). Female ABH were more likely to be in a relationship compared to female AVH (85% vs. 36%; p<0.0001) and 66% of ABH were married, whereas only 28% of AVH were (p = 0.03) (S3 Table). A higher proportion of female ABH (75%) had disclosed to their partners and were much less likely to report having used a condom at the last sex act (20%) compared to AVH, 44% of whom had disclosed to partners (p = 0.01) and 62% had used a condom at last sex (p = 0.004) (S5 Table).

Among male ALHIV, the majority (83%) were AVH and only 11 (17%) were ABH (S1 Table). Given the small sample size of ABH, there were few statistically significant differences observed according to mode of transmission for males. Similar to females, the male AVH were younger at treatment initiation, 12 years (IQR: 8–14), and study, 16 years (IQR: 15–18), compared to male ABH who were 17 years (IQR: 16–18) at ART initiation and 18 years (IQR: 17–19) at study (p<0.001; p<0.0001) (Table 1). A higher proportion of male ABH knew the names of their prescribed ARVs compared to AVH (36% vs. 4%, p = 0.006) (S2 Table).

Discussion

Our survey describes the socio-demographic, behavioral and psychosocial characteristics of ALHIV 15–19 years of age engaged in HIV services in Mozambique. It highlights the significant challenges faced by this highly vulnerable population. Overall, study participants were poor, had limited access to household facilities, and low cellphone ownership and internet access, as well as low levels of educational attainment and employment. Self-reported adherence was high (89% overall); however, almost half of ALHIV reported at least one missed ARV dose in the past 30 days and, among those with viral load test results, viral suppression rates were low. ALHIV in the study also demonstrated limited knowledge and understanding of HIV and ART, with only 4% able to name the ARVs they were prescribed. Very few ALHIV had disclosed their HIV status to friends or to sexual partners. Most ALHIV were sexually active, but few reported consistent condom use and 20% reported forced sex.

Taken together, these characteristics highlight the high degree and breadth of unmet needs in multiple areas among ALHIV. Our study was conducted in Nampula, Mozambique, which is an economically disadvantaged city in one of the poorest countries in the world [42]. However, reports from other countries in SSA have also shown poverty to be significant among ALHIV, including a study in South Africa of over 1,000 ALHIV 10–19 years of age in which 68% lacked at least one basic necessity [30], as well as a qualitative study in Kenya in which ALHIV identified poverty as a major challenge to remaining in care [43]. Despite poverty being complex and beyond the scope of traditional medical care, targeted efforts to improve the economic status of ALHIV may be warranted. Although data are limited, economic empowerment interventions have shown some success in improving treatment outcomes in ALHIV and should be considered for inclusion in multicomponent interventions [4446]. Other interventions at both the patient and health system levels have shown mixed results with regard to improving care outcomes in ALHIV [47,48], however there have been some promising findings from targeted adolescent-friendly services including expanded clinic hours and training for providers on adolescent care [44].

Stigma and fear about disclosure of HIV status were also major concerns for the ALHIV in our study as has been observed in other settings [39,49]. Stigma is a critically important factor to address with ALHIV as it has been associated with lack of retention in HIV services and poor adherence [50,51]. Assisting ALHIV with disclosure of HIV status to peers may be beneficial for reducing self-perceived stigma and building social support networks which can improve retention and ART adherence [39,50]. The low proportion of ALHIV in our study reporting disclosure to sexual partners, as well as condom use at last sex, along with the high rates of sexual activity and forced sex, have also been observed in other studies of ALHIV in SSA [18,52,53]. These data underscore the urgent need to strengthen sexual and reproductive health care for this population, and to provide support services for those who have been victims of gender-based sexual violence.

Our analysis also sheds new light on similarities and differences between males and females and likely mode of HIV transmission which can inform health and psychosocial intervention strategies aimed at improving the health of ALHIV. The majority (68%) in the cohort of ALHIV were female, and two-thirds (65%) were behaviorally infected. There were fewer males overall and unlike female ALHIV, most males (83%) had vertically acquired HIV. Our data are consistent with previous findings showing higher proportions of females among the ALHIV population in SSA which reflects disproportionately higher HIV acquisition as well as higher engagement in care among young women compared to men of similar age [29,54,55]. Despite previous documentation of sex differences among ALHIV [3,29,31,56], only a few studies have described this population according to mode of transmission in SSA where the majority of this population reside [30,31]. As such, our findings present important and novel data characterizing ALHIV, which will contribute to the design of more effective services globally for this group.

While our data illustrate the high level of deprivation and challenges faced by the ALHIV population overall, we also observed differences by sex and mode of HIV transmission. It should be noted that male study participants were almost entirely AVH, whereas females were primarily ABH, making it difficult to distinguish differences due to sex vs. mode of transmission. As expected, ABH of both sexes were older, had been on ART for less time and were less likely to be in school compared to AVH. Overall males were more likely than females to report alcohol use, and among ALHIV in relationships, ABH reported older partners and were more likely to have disclosed to their partners. Males overall were more likely than females to report missed ARV doses; however, using the three-item self-reported adherence scale, there were no differences across groups and all ALHIV in this study reported high adherence. The high levels of self-reported adherence may be due in part to social desirability which has been found in other studies [5759]. Sex differences in self-reported adherence have also been previously reported among adults with men being more likely to report missed doses [60]. However, while reported adherence was relatively good, viral suppression rates were poor and did not differ by mode of transmission or sex. With regard to stigma, females were more likely to report needing to conceal their HIV status and reported more concern about inadvertent disclosure, while high proportions of males, both AVH and ABH, reported feeling that they were partly to blame for their HIV. Overall, these findings demonstrate significant differences within the population of ALHIV and underscore the importance of developing gender sensitive interventions inclusive including stigma mitigation.

Female ABH in our study bear specific attention as they appear to be particularly vulnerable. They were the most socioeconomically disadvantaged with regard to household resources, two-thirds were not in school and half of those no longer in school had never finished primary level. Although we cannot distinguish whether the adolescent females in our cross-sectional study acquired HIV as a result of their vulnerability or whether their HIV status contributed to their poor socioeconomic status, our findings are consistent with previous studies which have identified poverty and lack of education as both drivers of HIV risk and as consequences of HIV infection for adolescent girls in SSA [6164]. Female ABH in our cohort also had the least knowledge about HIV transmission and viral load testing, and were more likely to say it was acceptable to miss medication doses. Previous studies have also shown that basic HIV knowledge is lower among adolescent girls and young women compared to men [13,65]. It is also important to note that just over half of female ABH in our study had a history of pregnancy, and among those pregnant at the time of the survey, few reported using contraception prior to the pregnancy despite half not intending to get pregnant. Low contraception use and high rates of unintended pregnancies have been reported previously in adolescent populations in SSA, including ALHIV [66,67]. These findings highlight the need to accelerate efforts to improving access to HIV prevention and sexual and reproductive health services for young women in Mozambique.

Our study did not include a comparison group of adolescents who do not have HIV so that we cannot ascertain whether the challenges faced by our cohort differ from those of other young people in Mozambique. The 2015 Mozambique Global School-Based Health Survey of a national representative sample of 16–17 year-old adolescents found similarly low use of alcohol (16%) and other drugs (2%), and a high proportion (64%) of young people reporting sexual activity [68]. Food insecurity and poverty are problems faced not only by ALHIV but widely across the population in Mozambique [69]. Lack of HIV knowledge is also common among ALHIV, particularly young women, and use of contraception is also limited among all adolescents. UNFPA estimates that only 19% of women and girls 15–19 have comprehensive knowledge about HIV [70]. Given the challenges faced by all ALHIV in Mozambique, it is somewhat encouraging that they appear to be similar to their peers in many ways. These findings suggest that interventions targeting all adolescents, in addition to those focused on ALHIV, are needed to improve the health and well-being of young people.

There are few data from SSA with which to compare our findings regarding differences by of HIV transmission mode because only a small number of studies have characterized ALHIV in this way [2931]. These studies also used different definitions of mode of transmission, mostly ART initiation <10 years as the main variable to distinguish AVH from ABH, whereas we used a cut-off of ART initiation at 15 years in our study. Our decision to use an older age cut-off was based on previous examinations of the ALHIV population showing advanced HIV disease among ALHIV 10–14 years of age suggestive of vertical rather than behavioral acquisition [4,71,72], as well as an investigation of population-level HIV prevalence data from Southern Africa which identified most ALHIV 10–14 years as AVH [7]. No studies, including our own, have included data on transmission mode collected directly from ALHIV or caregivers and instead rely on medical charts which are often missing the relevant data [56,73]. Future research involving ALHIV should include asking participants directly about mode of transmission, and additionally, it would be beneficial for the research community to agree upon a standard definition for using ART and demographic data as a proxy for mode of transmission.

Our analysis is unique in its description of characteristics of ALHIV across multiple domains by mode of transmission and sex. It is also novel for its setting, northern Mozambique, which has a large population of ALHIV about whom there are few data. We recruited participants from routine care settings, including antenatal clinics, to ensure inclusion of female ALHIV in order to more accurately describe the ALHIV population in this setting which is disproportionately female [8]. However, the study was based on a convenience sample of ALHIV actively engaged in care which limits our findings to adolescents in HIV services, the majority of whom were female. A limitation of the study is that we can only describe ALHIV enrolled in HIV services who represent only a portion of the population. In addition, loss to follow-up from care is high among adolescents [3,74] and our study was not designed to examine ALHIV who had disengaged from care nor to measure retention or treatment outcomes. While our aim was to describe ALHIV based on mode of transmission, participants were not asked about this directly and information in medical charts was not available. It is therefore possible that some ALHIV in this analysis were misclassified according to mode of transmission. In addition, because there were so few ABH males in care at the participating health facilities, our ability to identify differences by mode of transmission among males was limited.

In summary, our study provides new data on ALHIV in Mozambique, a country with one of the highest burdens of adolescent HIV in the world. We found that among Mozambican ALHIV engaged in HIV services, there was high level of deprivation with regard to resources, knowledge about HIV, adherence and reproductive health, and a high degree of self-perceived stigma. While the young men and women in the study faced many shared challenges, we also uncovered unique vulnerability by sex and mode of transmission which was particularly pronounced among young women with behaviorally acquired HIV. We believe that these data can contribute to more effective interventions for ALHIV through tailoring service interventions to meet the unique vulnerabilities of this population.

References

UNAIDS. Global AIDS Update 2020: Seizing the moment. Geneva, Switzerland: UNAIDS; 2020.

ONicholson, CMellins, CDolezal, EBrackis-Cott, EJAbrams. HIV treatment-related knowledge and self-efficacy among caregivers of HIV-infected children. Patient education and counseling. 2006;61(3):40510. 10.1016/j.pec.2005.05.006

MRLamb, RFayorsey, HNuwagaba-Biribonwoha, VViola, VMutabazi, TAlwar, et al. High attrition before and after ART initiation among youth (15–24 years of age) enrolled in HIV care. Aids. 2014;28(4):55968. 10.1097/QAD.0000000000000054

EKoech, CATeasdale, CWang, RFayorsey, TAlwar, INMukui, et al. Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya. Aids. 2014;28(18):272938. 10.1097/QAD.0000000000000473

JBNachega, MHislop, HNguyen, DWDowdy, REChaisson, LRegensberg, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. Journal of acquired immune deficiency syndromes. 2009;51(1):6571. 10.1097/QAI.0b013e318199072e

DEvans, CMenezes, KMahomed, PMacdonald, SUntiedt, LLevin, et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS research and human retroviruses. 2013;29(6):892900. 10.1089/AID.2012.0215

Low A, Teasdale CA, Brown K, Barradas DT, Mugurungi O, Sachathep K, et al. Epidemiology of HIV infection in adolescents in Southern Africa, and the burden of the undiagnosed: a multinational analysis of population-based survey data. 2020.

ALSlogrove, AHSohn. The global epidemiology of adolescents living with HIV: time for more granular data to improve adolescent health outcomes. Current opinion in HIV and AIDS. 2018;13(3):1708. 10.1097/COH.0000000000000449

UNAIDS AIDS Data Repository 2020 [October 25, 2020]. https://adr.unaids.org/naomi-data-package/mozambique-naomi-data-2020.

10 

UNAIDS. Women and HIV: A spotlight on adolescent girls and young women. Geneva, Switzerland2019.

11 

EJAbrams, RJSimonds, SModi, ERivadeneira, PVaz, CKankasa, et al. PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges. Journal of acquired immune deficiency syndromes. 2012;60 Suppl 3:S10512.

12 

UNAIDS. Start Free Stay Free: 2020 Progress Report. Geneva, Switzerland: UNAIDS; 2020.

13 

UNAIDS. Start Free Stay Free AIDS Free. In: HIV/AIDS JUNPo, editor. Geneva, Switzerland: UNAIDS; 2019.

14 

SSAKarim, CBaxter. HIV incidence rates in adolescent girls and young women in sub-Saharan Africa. The Lancet Global health. 2019;7(11):e1470e1. 10.1016/S2214-109X(19)30404-8

15 

LSteinberg. Cognitive and affective development in adolescence. Trends Cogn Sci. 2005;9(2):6974. 10.1016/j.tics.2004.12.005

16 

RCVreeman, AMGramelspacher, POGisore, MLScanlon, WMNyandiko. Disclosure of HIV status to children in resource-limited settings: a systematic review. Journal of the International AIDS Society. 2013;16:18466. 10.7448/IAS.16.1.18466

17 

LMMofenson, MFCotton. The challenges of success: adolescents with perinatal HIV infection. Journal of the International AIDS Society. 2013;16:18650. 10.7448/IAS.16.1.18650

18 

EToska, LDCluver, RHodes, KKKidia. Sex and secrecy: How HIV-status disclosure affects safe sex among HIV-positive adolescents. AIDS care. 2015;27 Suppl 1:4758. 10.1080/09540121.2015.1071775

19 

RCVreeman, BMMcCoy, SLee. Mental health challenges among adolescents living with HIV. Journal of the International AIDS Society. 2017;20(Suppl 3):21497. 10.7448/IAS.20.4.21497

20 

EDLowenthal, SBakeera-Kitaka, TMarukutira, JChapman, KGoldrath, RAFerrand. Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges. The Lancet infectious diseases. 2014;14(7):62739. 10.1016/S1473-3099(13)70363-3

21 

LJFrigati, WAmeyan, MFCotton, CLGregson, JHoare, JJao, et al. Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy. Lancet Child Adolesc Health. 2020;4(9):68898. 10.1016/S2352-4642(20)30037-7

22 

CJPearce, LFleming. Adherence to medication in children and adolescents with asthma: methods for monitoring and intervention. Expert Rev Clin Immunol. 2018;14(12):105563. 10.1080/1744666X.2018.1532290

23 

AWSmith, CAMara, ACModi. Adherence to antiepileptic drugs in adolescents with epilepsy. Epilepsy & behavior: E&B. 2018;80:30711. 10.1016/j.yebeh.2017.12.013

24 

JSBorus, LLaffel. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22(4):40511. 10.1097/MOP.0b013e32833a46a7

25 

SWoldesenbet, TKufa, MCheyip, KAyalew, CLombard, SManda, et al. Awareness of HIV-positive status and linkage to treatment prior to pregnancy in the "test and treat" era: A national antenatal sentinel survey, 2017, South Africa. PloS one. 2020;15(3):e0229874. 10.1371/journal.pone.0229874

26 

KRonen, CJMcGrath, ACLangat, JKinuthia, DOmolo, BSinga, et al. Gaps in Adolescent Engagement in Antenatal Care and Prevention of Mother-to-Child HIV Transmission Services in Kenya. Journal of acquired immune deficiency syndromes. 2017;74(1):307. 10.1097/QAI.0000000000001176

27 

MMustapha, VMusiime, SBakeera-Kitaka, JRujumba, NNabukeera-Barungi. Utilization of "prevention of mother-to-child transmission" of HIV services by adolescent and young mothers in Mulago Hospital, Uganda. BMC infectious diseases. 2018;18(1):566. 10.1186/s12879-018-3480-3

28 

NBCarbone, JNjala, DJJackson, MTEliya, CChilangwa, JTseka, et al. "I would love if there was a young woman to encourage us, to ease our anxiety which we would have if we were alone": Adapting the Mothers2Mothers Mentor Mother Model for adolescent mothers living with HIV in Malawi. PloS one. 2019;14(6):e0217693. 10.1371/journal.pone.0217693

29 

MMaskew, JBor, WMacLeod, SCarmona, GGSherman, MPFox. Adolescent HIV treatment in South Africa’s national HIV programme: a retrospective cohort study. The lancet HIV. 2019;6(11):e760e8. 10.1016/S2352-3018(19)30234-6

30 

LSherr, LDCluver, EToska, EHe. Differing psychological vulnerabilities among behaviourally and perinatally HIV infected adolescents in South Africa—implications for targeted health service provision. AIDS care. 2018;30(sup2):92101. 10.1080/09540121.2018.1476664

31 

BNNg’eno, TAKellogg, AAKim, AMwangi, MMwangi, JWamicwe, et al. Modes of HIV transmission among adolescents and young adults aged 10–24 years in Kenya. International journal of STD & AIDS. 2018;29(8):8005. 10.1177/0956462418758115

32 

Eunice Kennedy Shriver National Institute of Child NIoH. Prevention and Treatment through a Comprehensive Care Continuum of HIV-affected Adolescents in Resource Contrained Settings, website. 2020 [https://www.nichd.nih.gov/research/supported/PATC3H.

33 

SBaral, CHLogie, AGrosso, ALWirtz, CBeyrer. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC public health. 2013;13:482. 10.1186/1471-2458-13-482

34 

JGGarcía, MaCZea. Psychological interventions and research with Latino populations. Boston: Allyn and Bacon; 1997. xx, 284 p. p.

35 

IBWilson, YLee, JMichaud, FJFowler, WHRogers. Validation of a New Three-Item Self-Report Measure for Medication Adherence. AIDS and behavior. 2016;20(11):27008. 10.1007/s10461-016-1406-x

36 

IBWilson, FJFowler, CACosenza, JMichaud, JBentkover, ARana, et al. Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS and behavior. 2014;18(12):234958. 10.1007/s10461-013-0610-1

37 

LDCluver, RJHodes, EToska, KKKidia, FMOrkin, LSherr, et al. ’HIV is like a tsotsi. ARVs are your guns’: associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa. Aids. 2015;29 Suppl 1:S5765.

38 

BLFife, ERWright. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav. 2000;41(1):5067.

39 

CNostlinger, SBakeera-Kitaka, JBuyze, JLoos, ABuve. Factors influencing social self-disclosure among adolescents living with HIV in Eastern Africa. AIDS care. 2015;27 Suppl 1:3646. 10.1080/09540121.2015.1051501

40 

CAThoth, CTucker, MLeahy, SMStewart. Self-disclosure of serostatus by youth who are HIV-positive: a review. J Behav Med. 2014;37(2):27688. 10.1007/s10865-012-9485-2

41 

JHall, GBarrett, NMbwana, ACopas, AMalata, JStephenson. Understanding pregnancy planning in a low-income country setting: validation of the London measure of unplanned pregnancy in Malawi. BMC pregnancy and childbirth. 2013;13:200. 10.1186/1471-2393-13-200

42 

Program UND. UNDP Inequalities in human development in the 21st Century: Mozambique. New York, NY: UN; 2019.

43 

AAbubakar, FJRVan de Vijver, RFischer, ASHassan, KGJ, JTDzombo, et al. ’Everyone has a secret they keep close to their hearts’: challenges faced by adolescents living with HIV infection at the Kenyan coast. BMC public health. 2016;16:197. 10.1186/s12889-016-2854-y

44 

MCasale, ACarlqvist, LCluver. Recent Interventions to Improve Retention in HIV Care and Adherence to Antiretroviral Treatment Among Adolescents and Youth: A Systematic Review. AIDS patient care and STDs. 2019;33(6):23752. 10.1089/apc.2018.0320

45 

FMSsewamala, DDvalishvili, CAMellins, EHGeng, FMakumbi, TBNeilands, et al. The long-term effects of a family based economic empowerment intervention (Suubi+Adherence) on suppression of HIV viral loads among adolescents living with HIV in southern Uganda: Findings from 5-year cluster randomized trial. PLoS One. 2020;15(2):e0228370. 10.1371/journal.pone.0228370

46 

LGBermudez, FMSsewamala, TBNeilands, LLu, LJennings, GNakigozi, et al. Does Economic Strengthening Improve Viral Suppression Among Adolescents Living with HIV? Results From a Cluster Randomized Trial in Uganda. AIDS Behav. 2018;22(11):376372. 10.1007/s10461-018-2173-7

47 

LKReif, EJAbrams, SArpadi, BElul, MLMcNairy, DWFitzgerald, et al. Interventions to Improve Antiretroviral Therapy Adherence Among Adolescents and Youth in Low- and Middle-Income Countries: A Systematic Review 2015–2019. AIDS and behavior. 2020;24(10):2797810. 10.1007/s10461-020-02822-4

48 

PMacPherson, CMunthali, JFerguson, AArmstrong, KKranzer, RAFerrand, et al. Service delivery interventions to improve adolescents’ linkage, retention and adherence to antiretroviral therapy and HIV care. Tropical medicine & international health: TM & IH. 2015. 10.1111/tmi.12517

49 

MPantelic, MBoyes, LCluver, FMeinck. HIV, violence, blame and shame: pathways of risk to internalized HIV stigma among South African adolescents living with HIV. Journal of the International AIDS Society. 2017;20(1):21771. 10.7448/IAS.20.1.21771

50 

VMidtbo, VShirima, MSkovdal, MDaniel. How disclosure and antiretroviral therapy help HIV-infected adolescents in sub-Saharan Africa cope with stigma. Afr J AIDS Res. 2012;11(3):26171. 10.2989/16085906.2012.734987

51 

NAmmon, SMason, JMCorkery. Factors impacting antiretroviral therapy adherence among human immunodeficiency virus-positive adolescents in Sub-Saharan Africa: a systematic review. Public Health. 2018;157:2031. 10.1016/j.puhe.2017.12.010

52 

DSsewanyana, PNMwangala, Avan Baar, CRNewton, AAbubakar. Health Risk Behaviour among Adolescents Living with HIV in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018;2018:7375831. 10.1155/2018/7375831

53 

EToska, LDCluver, MEBoyes, MIsaacsohn, RHodes, LSherr. School, Supervision and Adolescent-Sensitive Clinic Care: Combination Social Protection and Reduced Unprotected Sex Among HIV-Positive Adolescents in South Africa. AIDS and behavior. 2017;21(9):274659. 10.1007/s10461-016-1539-y

54 

RNSsebunya, RKWanyenze, LNamale, HLukolyo, GPKisitu, PNahirya-Ntege, et al. Prevalence and correlates of HIV testing among adolescents 10–19 years in a post-conflict pastoralist community of Karamoja region, Uganda. BMC public health. 2018;18(1):612. 10.1186/s12889-018-5544-0

55 

SStaveteig, TNCroft, KTKampa, SKHead. Reaching the ’first 90’: Gaps in coverage of HIV testing among people living with HIV in 16 African countries. PloS one. 2017;12(10):e0186316. 10.1371/journal.pone.0186316

56 

ALSlogrove, MMahy, AArmstrong, MADavies. Living and dying to be counted: What we know about the epidemiology of the global adolescent HIV epidemic. Journal of the International AIDS Society. 2017;20(Suppl 3):21520. 10.7448/IAS.20.4.21520

57 

PTNieuwkerk, IMde Boer-van der Kolk, JMPrins, MLocadia, MASprangers. Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding. Antiviral therapy. 2010;15(6):9136. 10.3851/IMP1644

58 

MHKim, ACMazenga, XYu, SAhmed, MEPaul, PNKazembe, et al. High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors. Journal of the International AIDS Society. 2017;20(1):21437. 10.7448/IAS.20.1.21437

59 

ACMooney, CKCampbell, MJRatlhagana, JSGrignon, SMazibuko, EAgnew, et al. Beyond Social Desirability Bias: Investigating Inconsistencies in Self-Reported HIV Testing and Treatment Behaviors Among HIV-Positive Adults in North West Province, South Africa. AIDS and behavior. 2018;22(7):236879. 10.1007/s10461-018-2155-9

60 

RBijker, AJiamsakul, CKityo, SKiertiburanakul, MSiwale, PPhanuphak, et al. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts. Journal of the International AIDS Society. 2017;20(1):21218. 10.7448/IAS.20.1.21218

61 

LDCluver, RJHodes, LSherr, FMOrkin, FMeinck, PLim Ah Ken, et al. Social protection: potential for improving HIV outcomes among adolescents. Journal of the International AIDS Society. 2015;18(Suppl 6):20260. 10.7448/IAS.18.7.20260

62 

MMabaso, ZSokhela, NMohlabane, BChibi, KZuma, LSimbayi. Determinants of HIV infection among adolescent girls and young women aged 15–24 years in South Africa: a 2012 population-based national household survey. BMC public health. 2018;18(1):183. 10.1186/s12889-018-5051-3

63 

SJPascoe, LFLanghaug, WMavhu, JHargreaves, SJaffar, RHayes, et al. Poverty, food insufficiency and HIV infection and sexual behaviour among young rural Zimbabwean women. PloS one. 2015;10(1):e0115290. 10.1371/journal.pone.0115290

64 

OShisana, KRice, NZungu, KZuma. Gender and poverty in South Africa in the era of HIV/AIDS: a quantitative study. Journal of women’s health. 2010;19(1):3946. 10.1089/jwh.2008.1200

65 

SAButts, AKayukwa, JLanglie, VJRodriguez, MLAlcaide, NChitalu, et al. HIV Knowledge and Risk among Zambian Adolescent and Younger Adolescent Girls: Challenges and Solutions. Sex Educ. 2018;18(1):113. 10.1080/14681811.2017.1370368

66 

RCapurchande, GCoene, ISchockaert, MMacia, HMeulemans. "It is challenging… oh, nobody likes it!": a qualitative study exploring Mozambican adolescents and young adults’ experiences with contraception. BMC women’s health. 2016;16:48. 10.1186/s12905-016-0326-2

67 

BOAhinkorah. Predictors of unmet need for contraception among adolescent girls and young women in selected high fertility countries in sub-Saharan Africa: A multilevel mixed effects analysis. PloS one. 2020;15(8):e0236352. 10.1371/journal.pone.0236352

68 

UNESCO. Global School-based Student Health Survey: Mozambique 2015 Fact Sheet. Geneva, Switzerland2015.

69 

MPicolo, IBarros, MJoyeux, AGottwalt, EPossolo, BSigauque, et al. Rethinking integrated nutrition-health strategies to address micronutrient deficiencies in children under five in Mozambique. Matern Child Nutr. 2019;15 Suppl 1:e12721. 10.1111/mcn.12721

70 

UNFPA. Adolescents and Youth Dashboard—Mozambique 2020 [https://www.unfpa.org/data/adolescent-youth/MZ.

71 

RAFerrand, LMunaiwa, JMatsekete, TBandason, KNathoo, CENdhlovu, et al. Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2010;51(7):84451. 10.1086/656361

72 

JWEaton, GPGarnett, FRTakavarasha, PRMason, LRobertson, CMSchumacher, et al. Increasing adolescent HIV prevalence in Eastern Zimbabwe—evidence of long-term survivors of mother-to-child transmission? PloS one. 2013;8(8):e70447. 10.1371/journal.pone.0070447

73 

DMark, AArmstrong, CAndrade, MPenazzato, LHatane, LTaing, et al. HIV treatment and care services for adolescents: a situational analysis of 218 facilities in 23 sub-Saharan African countries. Journal of the International AIDS Society. 2017;20(Suppl 3):21591. 10.7448/IAS.20.4.21591

74 

CATeasdale, EJAbrams, KAYuengling, MRLamb, CWang, MVitale, et al. Expansion and scale-up of HIV care and treatment services in four countries over ten years. PloS one. 2020;15(4):e0231667. 10.1371/journal.pone.0231667